Knowledge, Attitudes and Practices Regarding HIV Amongst Women of Childbearing Age in the NYANGA Province, Gabon
A Mouinga-Ondémé, S Maghendji-Nzondo, J Buekens… - 2021 - researchsquare.com
Background: The seroprevalence of HIV in Gabon is 4.1%. This rate varies among its nine
provinces and is estimated at 4.2% in the province of Nyanga. This variance is believed to …
provinces and is estimated at 4.2% in the province of Nyanga. This variance is believed to …
Xiaojie Huang1†, Liumei Xu2†, Lijun Sun 1, Guiju Gao3, Weiping Cai 4, Yanfen Liu5, Haibo Ding6, Hongxia Wei 7, Ping Ma8, Min Wang9, Shuiqing Liu 10, Yaokai …
TH Mallhi, P Palumbo, S Qin, L Li - Evidence-Based Advance and …, 2021 - books.google.com
Huang et al. Kaletra Second-Line RWS in China had been on LPV/r-based second-line ART
treatment for more than one year after failure of any first-line ART regimen. Overall CD4+ T …
treatment for more than one year after failure of any first-line ART regimen. Overall CD4+ T …
High Natural Polymorphism in the gag Gene Cleavage Sites of non-B HIV Type 1 Isolates from Gabon
F Liégeois, DGI Reteno… - AIDS Research and …, 2013 - liebertpub.com
The main goal of the present study was to determine the frequency of substitutions in the
cleavage sites (CS) of gag gene among non-B HIV-1 isolates from Gabon. Fifty plasma …
cleavage sites (CS) of gag gene among non-B HIV-1 isolates from Gabon. Fifty plasma …
Quantification de la Charge Virale et tests de résistance du VIH-1 aux ARV à partir d'échantillons DBS (Dried Blood Spots) chez des patients Guinéens sous traitement …
AAM Diouara, HD Ndiaye, S Mboup… - African Journal of …, 2015 - journals.co.za
Problématique: Comme dans plusieurs pays du Sud, le suivi virologique des patients sous
traitement antirétroviral (TARV) en Guinée est timide voire inexistant dans certaines …
traitement antirétroviral (TARV) en Guinée est timide voire inexistant dans certaines …
Evaluation eines virologischen Therapie-Monitoring-Algorithmus und Identifikation medikamenten-assoziierter Resistenzmuster bei HIV-infizierten Personen unter …
T Burger - 2021 - edoc.ub.uni-muenchen.de
Das HI-Virus stellt mit weltweit etwa 38, 0 Millionen HIV-infizierten Menschen im Jahr 2019
Gesundheitssysteme vor allem in ressourcen-limitierten Settings vor große …
Gesundheitssysteme vor allem in ressourcen-limitierten Settings vor große …
From bedside to bench and back: future options for antiretroviral drugs in non-B HIV-1 subtypes
DT Njenda - 2020 - search.proquest.com
HIV-1 drug resistance remains a burden in low-and middle-income countries (LMIC).
Regardless of the advances in antiretroviral (ARV) therapy, there is an increase in the trend …
Regardless of the advances in antiretroviral (ARV) therapy, there is an increase in the trend …
Bases moléculaires de la résistance des VIH-1 de sous-types non B aux nouveaux antirétroviraux
DBF Kampo - 2014 - theses.hal.science
La disponibilité des antirétroviraux, ARV pour traiter les patients infectés par le VIH a été l'un
des plus grands défis de santé publique ces dernières années. Actuellement, de nouveaux …
des plus grands défis de santé publique ces dernières années. Actuellement, de nouveaux …
[PDF][PDF] Viral load suppression as a surrogate marker of treatment success in patients on antiretroviral therapy in Namibia
DC Mouton, M Gonzo, M Mukesi - Edorium J Biomed Sci, 2017 - researchgate.net
Aims: The study aimed to establish viral load suppression in patients on different
antiretroviral regimens in Namibia. Methods: This was a retrospective cross-sectional study …
antiretroviral regimens in Namibia. Methods: This was a retrospective cross-sectional study …
[图书][B] Food insecurity and disease: Prevalence, policy, and politics
A Hassan - 2017 - books.google.com
Food insecurity and disease are inextricably linked. The chapters in this valuable articles
compendium reinforce that message by specifically linking food insecurity to various forms of …
compendium reinforce that message by specifically linking food insecurity to various forms of …